Clinical trials
Terminated Phase 2 Gastrointestinal Stromal Tumors trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 2 |
| 2017 | 3 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| Columbia University | 1 |
| Eli Lilly and Company | 1 |
| Fox Chase Cancer Center | 1 |
| Kristen Ganjoo | 1 |
| M.D. Anderson Cancer Center | 1 |
| Sumitomo Pharma America, Inc. | 1 |
| University of Utah | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastrointestinal Stromal Tumors | 9 |
| Anemia, Iron-Deficiency | 1 |
| Brain Neoplasms | 1 |
| Carcinoma, Renal Cell | 1 |
| Kidney Neoplasms | 1 |
| Paraganglioma | 1 |
| Pheochromocytoma | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.